Comparing 3 approaches for metastatic colorectal cancer
Explore this study →
Sites in Ottawa and Toronto
Official title: A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)
Metastatic Colorectal Cancer · EMD Serono Research & Development Institute, Inc.